{
    "2018-02-21": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Is Amgen Inc. a Buy?",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Teva's Problems Continue to Mount With No Relief in Sight",
                "features": {
                    "keywords": [
                        "Teva",
                        "Problems",
                        "Mount",
                        "Relief"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "ACZ885: A Robust Treatment Option for Reducing Cardiovascular Risk?",
                "features": {
                    "keywords": [
                        "ACZ885",
                        "Robust",
                        "Treatment",
                        "Cardiovascular",
                        "Risk"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Analysts’ Recommendations for GlaxoSmithKline after 4Q17 Earnings",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommendations",
                        "GlaxoSmithKline",
                        "Earnings"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Novartis Plans to Expand its Multiple Sclerosis Portfolio in 2018",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Expand",
                        "Multiple Sclerosis",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "How Did JNJ’s Vision Care Segment Perform in 4Q17 and 2017?",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Vision Care",
                        "Segment",
                        "Perform"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Novartis Expects FDA and EMA Approvals for Aimovig in 2018",
                "features": {
                    "keywords": [
                        "Novartis",
                        "FDA",
                        "EMA",
                        "Approvals",
                        "Aimovig"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "The Swiss Stock Market Inched Higher As Heavyweights Underperform",
                "features": {
                    "keywords": [
                        "Swiss Stock Market",
                        "Inched Higher",
                        "Heavyweights",
                        "Underperform"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-15",
                "original_text": "Novartis CEO Steers Drug Maker Back to R&D",
                "features": {
                    "keywords": [
                        "Novartis",
                        "CEO",
                        "Drug Maker",
                        "R&D"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-16",
                "original_text": "Novartis Bribery Case in Greece Threatens to Bolster Populists",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Bribery",
                        "Case",
                        "Greece",
                        "Populists"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}